Auroricks

Roman name

Aurorix

The composition and the form of

1 tablet coated liner contains moklobemida 150 or 300 mg; blistere in 10 pcs. , in box 3 blisters.

Farmakodinamika

Improves mood and psihomotornuyu activity; Reduces symptoms of depression-disforiu, burnout, block, the inability to concentrate; ® sociofobi symptoms.

Indications

Depressive syndromes, sociofobia.

Pregnancy and lactation

Contraindicated.

Contraindications

Hypersensitivity, the acute consciousness child age simultaneous selegilina.

Side-Effects

Mental sleep ajitation, anxiety, irritability, dizziness, headaches, parestesia, vision, dry mouth, gastrointestinal violations skin reaction, signs of confusion (fast disappearing after preparation).

Patient interaction

Enhance and prolong the effect simpatomimetikov and possibly opiates. Increase the likelihood of adverse events of the central nervous system in combination with petidine, claumipraminom, dekstrometorfanom. Zimetidin biotransformatia slows.

Storage conditions

List B. In a dry, the dark place at a temperature of no higher than 25 ° C

Shelf life

5 years

The registration

015213/01-2003

Directory → Neurotropic funds → 24.2.1 → Auroricks